Real-world Evidence on Follitropin Delta Individual Dosing

RecruitingOBSERVATIONAL
Enrollment

850

Participants

Timeline

Start Date

December 8, 2021

Primary Completion Date

March 31, 2026

Study Completion Date

March 31, 2026

Conditions
InfertilitySterility
Interventions
DRUG

Follitropin delta

REKOVELLE® (follitropin delta), solution for injection - delivered with an injection pen, ATC code G03GA10, is a recombinant human FSH approved for the controlled ovarian stimulation for the development of multiple follicles in women undergoing assisted reproductive technologies such as an in vitro fertilisation or intracytoplasmic sperm injection cycle.

Trial Locations (1)

23562

RECRUITING

University of Luebeck, Lübeck

All Listed Sponsors
lead

University of Luebeck

OTHER